MARKSANS
Invest with MTF
Invest Now
Invest in Marksans Pharma with 2.88X leverage
Marksans Pharma live price: ₹168.04. It opened at ₹165 vs previous close ₹157; intraday high/low: ₹171/₹161. The 50 & 200 DMA stand at ₹171.84/₹189.46.
Marksans Pharma Performance
- Today's Low
- ₹161
- Today's High
- ₹171
- 52 Week Low
- ₹155
- 52 Week High
- ₹271
- Open Price₹165
- Previous Close₹157
- Volume917,509
- 50 DMA₹171.84
- 100 DMA₹177.63
- 200 DMA₹189.46
Investment Returns
- Over 1 Month -3.39%
- Over 3 Month -6.79%
- Over 6 Month + 1.82%
- Over 1 Year -24.47%
Smart Investing Starts Here Start SIP with Marksans Pharma for Steady Growth!
Marksans Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 21.1
- PEG Ratio
- -9.7
- Market Cap Cr
- 7,615
- P/B Ratio
- 2.7
- Average True Range
- 7.47
- EPS
- 7.95
- Dividend Yield
- 0.5
- MACD Signal
- -3.04
- RSI
- 49.47
- MFI
- 47.63
Marksans Pharma Financials
Marksans Pharma Technicals
EMA & SMA
Current Price
₹168.04
+
11.15
(7.11%)
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹167.24
- 50 Day
- ₹171.84
- 100 Day
- ₹177.63
- 200 Day
- ₹189.46
Resistance and Support
166.78
- R3 183.40
- R2 177.44
- R1 172.74
- S1 162.08
- S2 156.12
- S3 151.42
Marksans Pharma Corporate Actions - Bonus, Splits, Dividends
Marksans Pharma F&O
About Marksans Pharma
- NSE Symbol
- MARKSANS
- BSE Symbol
- 524404
- Chairman & Managing Director
- Mr. Mark Saldanha
- ISIN
- INE750C01026
Similar Stocks to Marksans Pharma
Popular Stocks
TCS Share PriceIRFC Share PriceIREDA Share PriceIRCTC Share PriceITC Share PriceWipro Share PriceSuzlon Share PriceTata Steel Share PriceYes Bank Share PriceHDFC Share PriceTata Power Share PriceInfosys Share PriceTata Motors Share PriceAdani Power Share PriceNHPC Share PriceRVNL Share PriceVedanta Share PricePaytm Share PriceLIC Share PriceBHEL Share Price
Marksans Pharma FAQs
Marksans Pharma share price is ₹168 As on 01 April, 2026 | 21:12
The Market Cap of Marksans Pharma is ₹7615 Cr As on 01 April, 2026 | 21:12
The P/E ratio of Marksans Pharma is 21.1 As on 01 April, 2026 | 21:12
The PB ratio of Marksans Pharma is 2.7 As on 01 April, 2026 | 21:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.